Search bioRxiv⌕ Search

Biology subjects

Wiench, M.

Publications and source records attributed to Wiench, M..

2 recordsLinked to original sources

An Organotypic Oral Squamous Cell Carcinoma Model Recapitulates Epithelial-Stromal Complexity at Single-cell Resolution and Reveals Matrix-derived Signalling as a Therapeutic Target.

Three-dimensional (3D) organotypic cultures recapitulate key structural features of oral tumours and provide controlled, ethical, and reproducible research platforms. However, their ability to faithfully recapitulate in vivo tissue composition and their translational relevance require rigorous validation. Here, we characterised a head and neck squamous cell carcinoma (HNSCC) model using single-cell RNA sequencing to assess maturation, cellular heterogeneity, functionality, and inter- and intra-tissue interactions within epithelial and stromal compartments. The epithelial layer of the model differentiated into populations closely resembling the tissue of tumour origin, including dividing and precursor cells, heterogeneous basal layer, suprabasal cells, and metabolically specialised populations. All epithelial lineages emerged from proliferative progenitors, driven by dynamic transcription factor programmes. The collagen-rich stroma contained functionally diverse fibroblasts reflecting the heterogeneity of cancer-associated fibroblasts in vivo, including dividing, matrix-producing, immune-responsive, and tumour-like populations. Importantly, extensive epithelial-stromal communication networks developed, essential for cancer epithelium maintenance and tumour microenvironment regulation. Matrix-derived signals, particularly fibronectin, osteopontin, and laminins, constituted dominant inputs to CD44-expressing cancer cells and are associated with patient survival in HNSCC, highlighting potential therapeutic targets. Overall, this organotypic HNSCC model exhibits high functional fidelity, captures key tumour elements relevant for therapy and resistance and brings confidence in non-animal drug testing.

cancer biology↗

A common analgesic enhances the anti-tumour activity of 5-aza-2'-deoxycytidine through induction of oxidative stress

The DNA demethylating agent 5-aza-2-deoxycytidine (DAC, decitabine) has anti-cancer therapeutic potential, but its clinical efficacy is hindered by DNA damage-related side effects. Here we describe how paracetamol augments the effects of DAC on cancer cell proliferation and differentiation, without enhancing DNA damage. Firstly, DAC specifically upregulates cyclooxygenase-2-prostaglandin E2 pathway, inadvertently increasing cancer cell survival, while the addition of paracetamol offsets this effect. Secondly, combined treatment leads to glutathione depletion and ROS accumulation with oxidative stress further enhanced by DAC suppressing anti-oxidant and thioredoxin responses. The benefits of combined treatment are demonstrated here in head and neck squamous cell carcinoma (HNSCC) and acute myeloid leukaemia cell lines, further corroborated in a HNSCC xenograft mouse model and through mining of publicly available DAC and paracetamol responses. In summary, the addition of paracetamol could allow for DAC dose reduction, widening its clinical usability and providing a strong rationale for consideration in cancer therapy.

cancer biology↗